Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/Canada/Survodutide
Purchase and availability checkSurvodutide in Canada

Can you buy Survodutide in Canada?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Survodutide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
Canada
Source records
3
Reviewed
July 24, 2026
ByPeptide Local Editorial DeskUpdated July 24, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Survodutide in Canada?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Survodutide is an investigational clinical program. No seller listing in Canada can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Survodutide in Canada?

Resolve the exact identity of Survodutide through SYNCHRONIZE-1 Phase 3 study - NCT06066515 from ClinicalTrials.gov. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.

03

Does an online listing prove Survodutide is authorized or available in Canada?

No. A page using the name Survodutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Survodutide clinical trials in Canada

8 study records currently list 77 locations in this country, including 11 locations individually marked Recruiting.

Registry update: July 24, 2026
Study records
8
Listed locations
77
Recruiting locations
11
Records with local recruiting sites
2
NCT06632444
Study-wide statusRecruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Listed locations
9
Recruiting locations
6
Registry update
2026-07-09
NCT06632457
Study-wide statusRecruiting

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Listed locations
6
Recruiting locations
5
Registry update
2026-07-09
NCT06077864
Study-wide statusCompleted

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Listed locations
25
Recruiting locations
0
Registry update
2026-07-23
NCT06066528
Study-wide statusCompleted

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Listed locations
11
Recruiting locations
0
Registry update
2026-06-24
NCT06066515
Study-wide statusCompleted

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

Listed locations
10
Recruiting locations
0
Registry update
2026-03-12
NCT04771273
Study-wide statusCompleted

A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

Listed locations
3
Recruiting locations
0
Registry update
2024-12-03
Continue the exact comparison

Related country and compound records.

Compare another tracked name in Canada, or keep Survodutide fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

Survodutide in North America

Survodutide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Survodutide is an investigational clinical program. No seller listing in Canada can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: SYNCHRONIZE-1 Phase 3 study - NCT06066515 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

SYNCHRONIZE-1 Phase 3 study - NCT06066515

SYNCHRONIZE-1 Phase 3 study - NCT06066515 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open SYNCHRONIZE-1 Phase 3 study - NCT06066515 ↗

Drug Product Database

Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drug Product Database ↗

Choosing a safe online pharmacy

Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Choosing a safe online pharmacy ↗
Canada / Country guide

Canada market context.

Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.

  • Health Canada’s April 2026 advisory names BPC-157, GHK-Cu, MOTS-C, and other unauthorized injectable peptides among examples it seized.
  • The federal Drug Product Database can be searched by DIN, product, ingredient, company, status, route, and dosage form.
  • Pharmacy licensing is provincial or territorial, so a Canadian address must still be matched to the appropriate regulator’s public record.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the DIN

Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.

02

Verify the pharmacy

Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.

03

Separate research labels

Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT06066515: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose WeightClinicalTrials.gov
02
Drug Product DatabaseHealth Canada
03
Choosing a safe online pharmacyHealth Canada
04
Unauthorized injectable peptide warningHealth Canada
05
Survodutide study search in CanadaClinicalTrials.gov
06
NCT06632444: LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisClinicalTrials.gov
07
NCT06632457: LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisClinicalTrials.gov
08
NCT06077864: A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)ClinicalTrials.gov
09
NCT06066528: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose WeightClinicalTrials.gov
10
NCT04771273: A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)ClinicalTrials.gov
Audit and handoff

Keep the exact record attached.